Pride of India — Hermetica Encyclopedia
Herb · African

Pride of India (Lagerstroemia speciosa)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Lagerstroemia speciosa leaves contain corosolic acid (a pentacyclic triterpenoid) and ellagitannins that lower blood glucose by enhancing cellular glucose uptake and inhibiting intestinal alpha-glucosidase enzymes. Preclinical studies demonstrate antidiabetic, antioxidant, and anti-inflammatory activity, including 30–38% protection of human red blood cell membranes at 50 µg/mL, though no human clinical trial data with quantified effect sizes are currently available.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordPride of India Banaba benefits
Pride of India close-up macro showing natural texture and detail — rich in cyclosporine, catalase, antioxidant
Pride of India — botanical close-up

Health Benefits

**Blood Glucose Regulation**
Corosolic acid and ellagitannins in mature leaves inhibit alpha-glucosidase and enhance glucose transport into cells, reducing postprandial glucose spikes in animal models of diabetes.
**Antioxidant Protection**
Phenolic acids, flavonoids, and ellagic acid scavenge reactive oxygen species, with ethyl acetate and ethanol leaf extracts demonstrating 30.01–37.50% protection of human RBC membranes against oxidative hemolysis at 50 µg/mL.
**Anti-Inflammatory Activity**
Leaf extracts suppress production of nitric oxide (NO), prostaglandin E2 (PGE2), interleukin-6 (IL-6), IL-1β, and TNF-α in LPS-stimulated macrophages via inhibition of iNOS, COX-2, MAPK phosphorylation, and NF-κB nuclear translocation.
**Immune Modulation**
Ethanol leaf extracts inhibit release of IL-2, IL-4, IL-5, IL-13, and TNF-α in Jurkat T-cell lines, suggesting potential in attenuation of T-cell-mediated inflammatory cascades.
**Potential Anticancer Effects**
Ethanolic leaf extracts exhibit pro-apoptotic activity and cell cycle arrest in liver cancer cell lines in vitro, attributed to ellagitannins and triterpenoids, though evidence remains preliminary and mechanistic details are incomplete.
**Digestive and Urinary Support**
Traditional use across India, the Philippines, and Southeast Asia includes bark decoctions for diarrhea and abdominal pain, and leaf preparations for urinary tract complaints, consistent with astringent tannin-mediated effects on mucosal tissues.
**Weight Management Support**
Indian folkloric tradition and some preclinical data suggest that leaf preparations may assist with obesity management, possibly through glucose metabolism modulation and appetite-related pathways, though human evidence is absent.

Origin & History

Pride of India growing in India — natural habitat
Natural habitat

Lagerstroemia speciosa is native to tropical and subtropical Asia, including India, the Philippines, Malaysia, and Southeast Asia, where it grows in moist deciduous forests and along riverbanks at low to mid elevations. The tree thrives in well-drained, fertile soils with high humidity and full sun exposure, reaching heights of 10–20 meters with distinctive pink-to-purple flowering clusters. It has been cultivated for millennia across South and Southeast Asia both as an ornamental tree and a medicinal resource, with the Philippines ('Banaba') and India representing the deepest traditional pharmacological knowledge bases.

Lagerstroemia speciosa has been documented in Ayurvedic texts and traditional Indian medicine for over a thousand years under various regional names, where it is reverently called a 'holy tree' associated in some traditions with the Bodhi tree linked to Buddha's enlightenment, lending it deep cultural and spiritual significance across South Asia. In the Philippines, where the plant is known as 'Banaba,' it has been a primary folk remedy for diabetes and kidney disorders for centuries, with red-leaf preparations considered especially potent; the Philippine herbal pharmacopoeia lists Banaba as one of ten priority medicinal plants for ongoing scientific validation. Traditional Chinese medicine and Southeast Asian healing systems have employed leaf, bark, root, and flower preparations for conditions including malaria, diarrhea, urinary tract infections, abdominal pain, and mouth ulcers, reflecting a broad empirical pharmacopoeia developed across diverse cultural contexts. Xhosa and Zulu traditional medicine practitioners in southern Africa have more recently adopted preparations from this tree for diabetes management, representing a cross-continental diffusion of ethnobotanical knowledge that researchers have identified as warranting formal validation studies.Traditional Medicine

Scientific Research

Research on Lagerstroemia speciosa is largely confined to in vitro cell culture studies and in vivo rodent models, with no peer-reviewed randomized controlled trials in human populations identified in the current literature. Preclinical studies have quantified membrane-protective antioxidant activity (30.01–37.50% RBC protection at 50 µg/mL), cytokine inhibition in Jurkat and macrophage cell lines, and corosolic acid concentrations in propagated plant material (0.012–0.062%), providing mechanistic plausibility for traditional antidiabetic use. A genus-level phytochemical survey identified 364 compounds and proposed 20 core antidiabetic components, but systematic dose-response and bioavailability data in humans are absent. The overall evidence base is preclinical and hypothesis-generating; multiple calls for well-designed human clinical trials appear in the literature, and the absence of standardized extract preparations further limits translational confidence.

Preparation & Dosage

Pride of India steeped as herbal tea — pairs with Lagerstroemia speciosa leaf extract is theorized to synergize with berberine (Berberis spp.) for blood glucose management, as both compounds modulate glucose uptake and alpha-glucosidase inhibition through partially overlapping but mechanistically distinct pathways—corosolic acid acting on GLUT4-mediated transport and berberine activating AMPK—potentially allowing additive effects at lower individual doses. Combination with
Traditional preparation
**Traditional Leaf Tea (Decoction)**
200–250 mL water for 10–15 minutes; consumed 1–2 times daily in Philippine and Indian traditional practice, with red-tinged mature leaves preferred for higher corosolic acid content
1–2 grams of dried Lagerstroemia speciosa leaves simmered in .
**Standardized Leaf Extract (Preclinical Reference)**
100–400 mg/kg body weight of ethanolic or methanolic extracts
Commercial extracts are sometimes standardized to 1–2% corosolic acid by HPLC, though no human clinical dose has been validated; animal studies typically use .
**Methanolic/Ethanolic Leaf Extract**
Used in most preclinical antidiabetic, antioxidant, and anti-inflammatory studies; concentrations of 50–200 µg/mL effective in cell culture models, with no established human equivalent dose.
**Bark Decoction**
Traditional preparation for gastrointestinal complaints—bark pieces boiled in water, strained, and taken orally; no standardized dose documented in peer-reviewed sources.
**Leaf Poultice**
Fresh or mashed leaves applied topically for fever reduction in some Southeast Asian traditions; no clinical validation for this route of administration.
**Timing Note**
Traditional use typically associates leaf tea with meals to leverage postprandial glucose effects; no pharmacokinetic data confirm optimal timing in humans.

Nutritional Profile

The leaves of Lagerstroemia speciosa are the primary medicinal part and contain a complex phytochemical matrix rather than significant macronutrient content. Key bioactives include corosolic acid (0.012–0.062% in mature leaves; 0.004–0.007% in young leaves), ellagitannins (lagerstroemin, flosin B, reginin A), oleanolic acid, ellagic acid, phenolic acids (gallic acid, protocatechuic acid), flavonoids (quercetin, kaempferol glycosides), flavones, anthocyanins, condensed tannins, and phenylpropanoids. Across the broader genus, 364 compounds have been characterized including alkaloids, terpenes, and glycosides. Bioavailability of corosolic acid and ellagitannins is not well characterized in humans; ellagitannins are known in related plants to be metabolized by gut microbiota into urolithins, which may carry independent bioactivity, but this has not been directly studied for Lagerstroemia speciosa.

How It Works

Mechanism of Action

Corosolic acid, the primary triterpenoid in Lagerstroemia speciosa leaves (0.012–0.062% in mature leaves), enhances glucose uptake in peripheral tissues by mechanisms proposed to include GLUT4 transporter activation and insulin receptor sensitization, while also inhibiting intestinal alpha-glucosidase to reduce carbohydrate hydrolysis and postprandial glucose absorption. Ellagitannins and ellagic acid contribute complementary antidiabetic activity and exert free-radical scavenging through electron donation and metal chelation, reducing oxidative stress biomarkers in preclinical models. Anti-inflammatory effects proceed through suppression of the NF-κB signaling pathway—blocking nuclear translocation of p65 subunit—alongside inhibition of MAPK phosphorylation cascades (ERK, JNK, p38), resulting in downstream reduction of COX-2 and iNOS gene expression and consequent decreases in PGE2 and NO production. At least 20 core compounds identified across the genus (including oleanolic acid, flavonoids, and phenylpropanoids) are considered synergistically active, though the precise receptor-binding affinities and pharmacokinetic parameters of most constituents in humans remain poorly characterized.

Clinical Evidence

No human clinical trials with defined sample sizes, randomization protocols, or statistically reported effect sizes have been published for Lagerstroemia speciosa as a primary intervention for diabetes or any other condition as of the current evidence review. Available human-adjacent data consist of ex vivo assays, such as red blood cell membrane protection experiments, which provide mechanistic but not efficacy data. The preclinical animal studies supporting antidiabetic effects have not been replicated in controlled human studies, meaning that blood glucose-lowering claims cannot be assigned a confirmed effect size or confidence interval. Confidence in clinical benefit remains low by evidence-based medicine standards, and any therapeutic application should be regarded as experimental pending adequately powered human trials.

Safety & Interactions

Human safety data for Lagerstroemia speciosa are limited; no formal toxicology studies in humans have been published, and while preclinical profiles suggest relatively low acute toxicity, chronic safety parameters remain undefined and caution is warranted for long-term use. The most significant inferred drug interaction risk is pharmacodynamic potentiation with antidiabetic medications (metformin, sulfonylureas, insulin, SGLT2 inhibitors), where additive glucose-lowering effects could precipitate hypoglycemia; blood glucose monitoring is advisable if co-administered. Individuals with kidney disease should exercise caution given the high tannin content, which in excess may adversely affect renal tubular function, and the traditional use of the plant for urinary complaints does not confirm renal safety at supplemental doses. No clinical guidance exists for use during pregnancy or lactation, and given the absence of safety data in these populations, use should be avoided; individuals on anticoagulant therapy should note that ellagic acid and phenolic compounds may theoretically affect platelet aggregation, though this has not been clinically quantified.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Lagerstroemia speciosaBanabaGiant Crape MyrtleQueen's Crape MyrtleJarulPride of India

Frequently Asked Questions

What is Pride of India (Banaba) used for medicinally?
Pride of India (Lagerstroemia speciosa) is primarily used in traditional medicine across India, the Philippines, and Southeast Asia for blood sugar management in diabetes, as well as for diarrhea, urinary tract complaints, and weight management. Its leaves contain corosolic acid and ellagitannins, which in preclinical studies inhibit alpha-glucosidase and enhance glucose uptake. While traditional use is extensive, human clinical trial data confirming these effects are currently lacking.
How does Banaba leaf lower blood sugar?
Banaba leaf contains corosolic acid, a triterpenoid that is proposed to enhance glucose uptake in peripheral cells by activating glucose transporter proteins (notably GLUT4) and sensitizing insulin signaling pathways. Additionally, corosolic acid and ellagitannins inhibit intestinal alpha-glucosidase, slowing carbohydrate digestion and reducing postprandial blood glucose spikes. These mechanisms are supported by in vitro and animal studies; human pharmacokinetic and efficacy data are not yet established.
What is the recommended dosage of Banaba leaf extract?
No evidence-based human dosage for Banaba leaf extract has been established through clinical trials. Traditional preparations use 1–2 grams of dried mature leaves brewed as a tea once or twice daily, with red-tinged leaves preferred for higher corosolic acid content (0.012–0.062%). Commercial extracts are sometimes standardized to 1–2% corosolic acid, but optimal human doses, dosing frequency, and duration of use remain undefined pending clinical research.
Is Pride of India (Banaba) safe to take with diabetes medication?
Combining Banaba leaf preparations with antidiabetic drugs such as metformin, sulfonylureas, or insulin carries a theoretical risk of additive hypoglycemia, given that corosolic acid and ellagitannins lower blood glucose through independent mechanisms. No formal drug interaction studies in humans have been conducted, so caution and blood glucose monitoring are recommended if co-administration is considered. Consultation with a healthcare provider is strongly advised before adding Banaba to any existing diabetes treatment regimen.
What are the side effects of Banaba leaf?
Human safety data for Lagerstroemia speciosa are very limited; no controlled toxicology studies in people have been published, and formal side effect profiles have not been established. Preclinical data suggest relatively low acute toxicity, but the high tannin content in leaves could potentially irritate the gastrointestinal tract or affect kidney function with prolonged high-dose use. Until human safety studies are completed, use during pregnancy, lactation, or in individuals with kidney disease or those taking blood-thinning medications should be avoided.
What is the difference between Banaba leaf extract and whole leaf powder forms?
Banaba leaf extract is concentrated through solvent extraction (typically ethanol or water), delivering higher levels of active compounds like corosolic acid and ellagitannins in smaller doses, while whole leaf powder provides the full plant matrix with lower bioactive concentrations. Clinical studies showing blood sugar effects typically use standardized extracts containing 1–2% corosolic acid, making extracts more reliable for consistent dosing. Whole leaf powder may offer additional phytonutrients but requires larger serving sizes to achieve equivalent levels of the key active compounds.
Is Pride of India (Banaba) safe to use during pregnancy or while breastfeeding?
There is insufficient clinical evidence to establish the safety of Banaba leaf supplementation during pregnancy or lactation, so it is generally not recommended during these periods without medical supervision. The blood glucose-lowering properties could potentially affect maternal or fetal glucose metabolism, which is a critical concern during pregnancy. Women who are pregnant or breastfeeding should consult their healthcare provider before using Banaba supplements.
What clinical evidence supports the antioxidant claims for Banaba leaf?
In vitro studies demonstrate that Banaba leaf extracts (particularly ethanol and ethyl acetate preparations) exhibit 30–37.5% free radical scavenging activity through their phenolic acids, flavonoids, and ellagic acid content. However, most published antioxidant research is conducted in laboratory or animal models, with limited human clinical trials specifically measuring oxidative stress reduction in vivo. While the antioxidant potential is biochemically plausible, stronger human clinical evidence is needed to confirm clinically meaningful antioxidant benefits in supplement users.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.